Article

The role of garlic in hepatopulmonary syndrome: A randomized controlled trial

Department of Medicine, Medical College Calcutta, India.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie (Impact Factor: 1.97). 03/2010; 24(3):183-8.
Source: PubMed

ABSTRACT Increased nitric oxide production in cirrhosis has been commonly implicated in the genesis of hepatopulmonary syndrome (HPS). Initial studies suggested that garlic, a constituent of the daily diet, may have a role in the treatment of HPS by altering nitric oxide production.
To evaluate the effects of oral garlic supplementation on arterial blood gas parameters, and overall morbidity and mortality in patients with HPS.
Twenty-one and 20 HPS patients were randomly assigned to receive either oral garlic supplementation or placebo, respectively, and were evaluated monthly over a period of nine to 18 months.
After nine months, garlic supplementation was associated with a 24.66% increase in baseline arterial oxygen levels (83.05 mmHg versus 66.62 mmHg; P<0.001), compared with only a 7.37% increase (68.75 mmHg versus 64.05 mmHg; P=0.02) among subjects in the placebo group. There was also a 28.35% decrease in alveolar-arterial oxygen gradient (21.35 mmHg versus 29.77 mmHg; P<0.001) among patients with HPS who received garlic, in contrast with only a 10.73% decrease (29.11 mmHg versus 32.61 mmHg; P=0.12) among those in the placebo group. After nine months, the arterial oxygen level was significantly higher (83.05 mmHg versus 68.75 mmHg; P<0.001) and the alveolar-arterial oxygen gradient was significantly lower (21.35 mmHg versus 29.11 mmHg; P<0.001) among patients receiving garlic compared with those receiving placebo. Reversal of HPS was observed in 14 of 21 patients (66.67%) on garlic supplementation (intent-to-treat analysis) and in one of 20 patients (5%) on placebo. Two of 21 patients undergoing garlic supplementation died during follow-up in contrast to seven of 20 patients who were on placebo.
Garlic supplementation may be beneficial in patients with HPS for the reversal of intrapulmonary shunts as well as reducing hypoxemia and mortality.

Download full-text

Full-text

Available from: Deep Dutta, Jul 06, 2015
0 Followers
 · 
163 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatopulmonary syndrome (HPS) is the association of liver disease, hypoxemia, and intrapulmonary vascular dilatations. There are little data on the management of HPS in children other than conventional orthotopic liver transplantation (OLT). To describe the patient characteristics, mode of diagnosis, treatment, and outcomes of children with HPS at our center. Retrospective review of patients diagnosed with HPS between 1997 and 2007 after IRB approval. There were 10 patients, six females; median age at diagnosis of HPS was 12 yr. Six with cirrhosis underwent OLT and had subsequent resolution of HPS and are stable at last follow-up. Of the remaining four, two had cirrhosis. HPS resolved without conventional OLT in the following four patients: hepatitis C after antiviral treatment, biliary atresia with portal hypertension after transjugular intrahepatic portosystemic shunting, Abernethy syndrome after auxiliary partial OLT, and in a child with splenic vein thrombosis after splenectomy. Our series shows resolution of HPS in all patients and 100% survival after conventional OLT. Four children had resolution of HPS after surgical or medical treatments other than conventional OLT. Careful review of clinical status and underlying pathophysiology and anatomy at diagnosis of HPS should inform treatment decisions.
    Clinical Transplantation 12/2010; 25(6):849-55. DOI:10.1111/j.1399-0012.2010.01378.x · 1.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatopulmonary syndrome (HPS) is a serious vascular complication of liver disease that occurs in 5-32% of patients with cirrhosis. The presence of HPS markedly increases mortality. No effective medical therapies are currently available and liver transplantation is the only established treatment option for HPS. The definition and diagnosis of HPS are established by the presence of a triad of liver disease with intrapulmonary vascular dilation that causes abnormal arterial gas exchange. Experimental biliary cirrhosis induced by common bile duct ligation in the rat reproduces the pulmonary vascular and gas exchange abnormalities of human HPS and serves as a pertinent animal model. Pulmonary microvascular dilation and angiogenesis are two central pathogenic features that drive abnormal pulmonary gas exchange in experimental HPS, and thus might underlie HPS in humans. Defining the mechanisms involved in the microvascular alterations of HPS has the potential to lead to effective medical therapies. This Review focuses on the current understanding of the pathogenesis, clinical features and management of HPS.
    Nature Reviews Gastroenterology &#38 Hepatology 07/2012; 9(9):539-49. DOI:10.1038/nrgastro.2012.123 · 10.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and objective: Garlic has been widely used in clinical practice, and there were many systematic reviews (SRs) describing its effects. But none reviewed the clinical utility comprehensively, so we aimed to evaluate its effects from every aspect of its effects. Methods: We comprehensively searched medical electronic databases, asked the experts in this field, along with reference tracking, and manual searching. We included all kinds of SRs, including Cochrane SRs and non-Cochrane SRs. Two authors independently selected articles for relevant SRs, and extracted data of included SRs, resolved differences by consultation with a third reviewer. Results: We described nine SRs about garlic. Available evidence showed that garlic can reduce blood pressure (BP) in hypertensive patients and patients with elevated systolic BP (SBP), but not in normotensive subjects. Evidence about the effects of garlic on lipid parameters was contentious, so we cannot make a decision whether garlic is effective enough for reducing total cholesterol (TC), triglycerides (TAG), and high-density lipoprotein (HDL). As evidence was very limited and insufficient, relations between garlic intake and reduced risks of all kinds of cancers, antiglycemic and antithrombotic effects of garlic, the effects of garlic on cardiovascular morbidity and mortality were unclear. Garlic as a preventative or treatment option for the common cold or peripheral arterial occlusive disease or pre-eclampsia and its complications could not be recommended, as only one relatively small trial evaluated the effects separately. Conclusions: Garlic might be effective in some areas of clinical practice, but the evidence levels were low, so further researches should be well designed using rigorous method to avoid potential biases.
    Critical reviews in food science and nutrition 01/2013; 53(7):670-81. DOI:10.1080/10408398.2010.537000 · 5.55 Impact Factor